Hatem Raja, Bebawi Emmanuel, Schampaert Erick
Cardiology Department, Hôpital du Sacré-Cœur de Montréal, Université de Montréal, Montréal, Québec, Canada.
Cardiology Department, Hôpital du Sacré-Cœur de Montréal, Université de Montréal, Montréal, Québec, Canada.
Can J Cardiol. 2017 Jun;33(6):830.e17-830.e18. doi: 10.1016/j.cjca.2017.03.002. Epub 2017 Mar 9.
Small-molecule multitargeted tyrosine kinase inhibitor (TKI) therapy is used in different types of cancer. These drugs have been associated with cardiovascular toxicity, including aortic dissection. To our knowledge, this is the first time that a coronary dissection potentially associated with a TKI treatment has been described.
小分子多靶点酪氨酸激酶抑制剂(TKI)疗法用于不同类型的癌症。这些药物与心血管毒性有关,包括主动脉夹层。据我们所知,这是首次描述可能与TKI治疗相关的冠状动脉夹层。